Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-10-02 Biller Scott Chief Scientific Officer Sale −955 $67.23 $64K 6,264
2017-10-02 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −1,191 34,090
2017-10-02 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −955 34,331
2017-10-02 Schenkein David P Chief Executive Officer Option exercise +6,000 $0.30 $2K 6,000
2017-10-02 Schenkein David P Chief Executive Officer Sale −6,000 $66.76 $401K 0
2017-10-02 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −6,000 112,656
2017-09-18 Schenkein David P Chief Executive Officer Option exercise +35,000 $0.30 $11K 35,000
2017-09-18 Schenkein David P Chief Executive Officer Sale −35,000 $67.12 $2.3M 0
2017-09-18 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −35,000 118,656
2017-09-14 Cantley Lewis Clayton Jr. Director Sale −1,000 $65.71 $66K 85,394
2017-09-14 Cantley Lewis Clayton Jr. Director Sale −1,000 $65.71 $66K 85,434
2017-09-13 Cantley Lewis Clayton Jr. Director Sale −1,000 $65.47 $65K 86,394
2017-09-13 Cantley Lewis Clayton Jr. Director Sale −1,000 $65.47 $65K 86,434
2017-09-11 Bowden Christopher Chief Medical Officer Option exercise +6,000 $35.16 $211K 6,881
2017-09-11 Bowden Christopher Chief Medical Officer Sale −6,000 $65.00 $390K 881
2017-09-11 Bowden Christopher Chief Medical Officer Option exercise · Stock option (right to buy) −6,000 109,000
2017-09-11 Biller Scott Chief Scientific Officer Sale −15,000 $65.00 $975K 10,470
2017-09-07 Schenkein David P Chief Executive Officer Gift −500 271,772
2017-09-01 Biller Scott Chief Scientific Officer Option exercise +2,146 $9.05 $19K 8,410
2017-09-01 Biller Scott Chief Scientific Officer Sale −2,146 $61.99 $133K 6,264

Page 72 of 80 · 1,590 trades